ARTreat (IP) PDF | Print | E-mail

Multi-level patient-specific artery and atherogenesis model for outcome prediction, decision support treatment, and virtual hand-on training (ARTREAT)

Contact the ARTREAT Coordinator:

Dr Dimitrios Gritsis

(Project Coordinator)
Sword Technologies SA
105 Route D'Arlon, 8009, Strassen, Luxembourg

email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

ARTREAT participants

• UNIVERSITA DEGLI STUDI DI PARMA
• CONSIGLIO NAZIONALE DELLE RICERCHE
• D.D. SYNERGY HELLAS ANONYMI EMPORIKI ETAIREIA PAROCHIS YPIRESION PLIROFORIKIS
• WORLD MATCH LIMITED
• AGFA HEALTHCARE N.V.
• SORIN BIOMEDICA CARDIO S.R.L.
• EURO (PMS) LIMITED
• INTERCON SP. Z O.O.
• UNIVERSITE PARIS DESCARTES
• ADVANCED SIMULATION AND DESIGN GMBH
• THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
• FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS
• TECMIC-TECNOLOGIAS DE MICROELECTRONICA SA
• LANZA & THOMPSON INFORMATION TECHNOLOGY SRL
• SAS SOFTWARE LIMITED
• TECHNOLOGICA EOOD
• COMPUTER SHARING BUCURESTI SRL
• UNIVERZITET U KRAGUJEVCU

 

 

 

 

 

 

 

 

 

 

 

 

ARTreat targets at providing a patient-specific computational model of the cardiovascular system, used to improve the quality of prediction for the atherosclerosis progression and propagation into life-threatening events that need to be treated accordingly.

ARTreat will provide a three-level patient model describing the 3d arterial tree anatomy, the patient-specific blood flow and blood particle dynamics and the biological processes that lead to the creation and progression of atherosclerotic plaques.

ARTreat will apply the developed patient-specific model on two main applications: the clinical decision support and the training. ARTreat will produce two decision support tools to assist clinical cardiologists into providing personalized treatment selection and real-time, on- the-fly advice during invasive interventions, such stent positioning. The aim is to minimize future therapy costs, by providing higher than even possible personalized treatment support. The same patient-specific model will also be used to develop a real-case simulator training, which will support realistic hands-on skill development training to clinical cardiologists.

Finally, ARTreat is coupled with advanced clinical support tools for plaque characterization, and the discovery of new knowledge; associations among heterogeneous data, that can improve the predictive power of the patient-model. It thus supports the medical expert into programming the accumulated knowledge into the existing model and generating an adaptive patient-specific computational tool. Key market players AGFA and SORIN will exploit the ARTreat applications to provide new sophisticated solutions to their product range, while all academic and IT company partners will accumulate significant experience on the new generation patient-specific healthcare services.

For more information on ARTreat click here